Avnet logo

AvnetNASDAQ: AVT

Profile

Sector:

Technology

Country:

United States

IPO:

03 May 1973

Next earnings report:

31 January 2025

Last dividends:

11 September 2024

Next dividends:

N/A
$4.78 B
-3%vs. 3y high
74%vs. sector
-3%vs. 3y high
13%vs. sector
-16%vs. 3y high
27%vs. sector
-4%vs. 3y high
8%vs. sector

Price

regular market | 1 min ago
$54.96+$0.42(+0.77%)
$5.60 B$5.55 B
$5.60 B$58.96 M

Analysts recommendations

Institutional Ownership

AVT Latest News

International Markets and Avnet (AVT): A Deep Dive for Investors
zacks.com04 November 2024 Sentiment: -

Examine Avnet's (AVT) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
globenewswire.com04 November 2024 Sentiment: POSITIVE

REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT05, Alvotech's proposed biosimilar to Simponi® (golimumab), a biologic used to treat several chronic inflammatory diseases. This is believed to be the first marketing authorization application filing announced globally for a biosimilar candidate to Simponi. The approvals process is anticipated to be completed in the fourth quarter of 2025.

Here's What Key Metrics Tell Us About Avnet (AVT) Q1 Earnings
zacks.com30 October 2024 Sentiment: POSITIVE

While the top- and bottom-line numbers for Avnet (AVT) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
globenewswire.com10 October 2024 Sentiment: POSITIVE

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT03, a proposed biosimilar candidate to Prolia® and Xgeva® (denosumab).

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
globenewswire.com10 October 2024 Sentiment: POSITIVE

REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT03, a proposed biosimilar candidate to Prolia® and Xgeva® (denosumab).

Avnet to Support South East Water's Mass Digital Meter Deployment
businesswire.com12 September 2024 Sentiment: POSITIVE

MELBOURNE, Australia--(BUSINESS WIRE)---- $AVT #Avnet--Avnet has been awarded the contract to supply Huizhong's SCL61H-100 smart ultrasonic water meters to South East Water (SEW).

Wall Street's Favorite Passive Income Stock and 2 Others Raising Dividends This Week
247wallst.com19 August 2024 Sentiment: POSITIVE

24/7 Wall St. Insights Companies that raise their dividends regularly are outstanding ideas for investors.

Avnet Names Ginnie Henkels and Helmut Gassel to its Board of Directors
businesswire.com15 August 2024 Sentiment: POSITIVE

PHOENIX--(BUSINESS WIRE)-- #Avnet--Avnet names Ginnie Henkels and Helmut Gassel to its Board of Directors.

European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
globenewswire.com15 August 2024 Sentiment: POSITIVE

REYKJAVIK, Iceland and LONDON, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT06, Alvotech's proposed biosimilar to Eylea® (aflibercept). The process to obtain marketing authorization could be completed in the third quarter of 2025.

Avnet (AVT) Reliance on International Sales: What Investors Need to Know
zacks.com12 August 2024 Sentiment: POSITIVE

Explore how Avnet's (AVT) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

What type of business is Avnet?

Avnet, Inc. is a distributor of electronic components. The company has been in operation since 1921 and was registered in New York in 1955. The electronic components group sells electronic components, including semiconductors, interconnects, passive and electromechanical components, as well as other integrated components from leading global electronic component manufacturers primarily for large customers. The Farnell group, on the other hand, supports customers with small sales volumes who need electronic components for rapid development, prototyping, and testing of their products. Farnell distributes a wide range of kits, tools, electronic components, industrial automation components, as well as products for testing and measurement.

What sector is Avnet in?

Avnet is in the Technology sector

What industry is Avnet in?

Avnet is in the Electronics & Computer Distribution industry

What country is Avnet from?

Avnet is headquartered in United States

When did Avnet go public?

Avnet initial public offering (IPO) was on 03 May 1973

What is Avnet website?

https://www.avnet.com

Is Avnet in the S&P 500?

No, Avnet is not included in the S&P 500 index

Is Avnet in the NASDAQ 100?

No, Avnet is not included in the NASDAQ 100 index

Is Avnet in the Dow Jones?

No, Avnet is not included in the Dow Jones index

When was Avnet the previous earnings report?

No data

When does Avnet earnings report?

The next expected earnings date for Avnet is 31 January 2025